Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, K. Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, M. Dib, R. Hall, Henry Jardel, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, Nicolas Leupin, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon (2015). Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma. , 101(3), DOI: https://doi.org/10.3324/haematol.2015.133629.
Article23 days agoContinuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, Karim Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon (2015). Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial. , 15, DOI: https://doi.org/10.1016/j.clml.2015.07.339.
Article23 days agoImpact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results
Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Guenter Derigs, Hyeon Seok Eom, Karim Belhadj, Pascal Lenain, Richard H. van der Jagt, Sophie Rigaudeau, Mamoun Dib, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, William Bensinger, Rik Schots, Guang Chen, Jennifer Marek, Annette Ervin‐Haynes, Thierry Façon (2014). Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results. , 124(21), DOI: https://doi.org/10.1182/blood.v124.21.2112.2112.
Article23 days ago